Medical/Pharmaceuticals

Seegene Showcases HPV Diagnostic Kits and PCR Technology at AOGIN 2024

* Showcases Allplex™ HPV products designed to test for 14 high-risk HPV genotypes   * Advocates HPV testing for early diagnosis and prevention of cervical cancer  * Aims to accelerate the widespread adoption of syndromic PCR testing to create "a world free from all diseases" SEOUL, South Kore...

2024-07-16 21:00 3241

SPI Pharma, Inc. and Inimmune, Corp. Partner to Develop and Commercialize Innovative Vaccine Adjuvant Systems

WILMINGTON, Del., July 16, 2024 /PRNewswire/ -- SPI Pharma, Inc. a global leader in biopharmaceutical excipient and adjuvant systems, and Inimmune, Corp., a pioneering biotechnology company specializing in the discovery and development of innate immune modulators, announce an agreement in princip...

2024-07-16 21:00 1883

Shaping the Future: Forum 30, The MPHO Safety and Traceability Summit in Rome

REDLANDS, Calif., July 16, 2024 /PRNewswire/ -- The International Council for Commonality in Blood Banking Automation ("ICCBBA"), in partnership with the Italian national competent authorities for bloodCentro Nazionale Sangue ("CNS") and cells/tissuesCentro Nazionale Trapianti ("CNT"), will be ho...

2024-07-16 21:00 1854

Sanyou Bio Collaborates on ADC Drug Development Entering Phase I Clinical Trials

SHANGHAI, July 16, 2024 /PRNewswire/ -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") has recently announced a significant milestone in collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Huadong Medicine C...

2024-07-16 20:00 2386

Metabolon Expands Library to Include 70 Pesticides, Advancing Human Exposome Insights through Metabolomics

MORRISVILLE, N.C., July 16, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced the expansion of its metabolite libr...

2024-07-16 19:45 1882

Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma

SINGAPORE, July 16, 2024 /PRNewswire/ -- Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) inChina has approved the initiation of a...

2024-07-16 19:29 2748

Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma

SINGAPORE, July 16, 2024 /PRNewswire/ -- Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) inChina has approved the initiation of a...

2024-07-16 17:10 2903

WIPO Honours Vivo Surgical with Global Accolade for Innovation and IP Excellence

Pioneering Singaporean surgical robotics company selected from over 660 applicants worldwide to emerge as a winner of the coveted WIPO Global Awards for 2024 GENEVA, July 16, 2024 /PRNewswire/ -- Vivo Surgical, a privately-held medical technology company pioneering a flexible endoscopic robot fo...

2024-07-16 16:45 15986

Mabwell Receives NMPA Approval for Clinical Trial of Novel Nectin-4 Targeting ADC in TNBC

SHANGHAI, July 15, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel Nectin-4 targeting ADC (R&D code: 9MW2821) has been approved by the NMPA to enter Phase II clinical trial as monotherapy or in combination with a PD...

2024-07-15 22:00 2437

In Honor of World Brain Day, the World Federation of Neurology to Host Free Public Webinar to Spotlight Brain Health and Disease Prevention

LONDON, July 15, 2024 /PRNewswire/ -- The World Federation of Neurology (WFN) is hosting its 11th annual World Brain Day on July 22. This year, World Brain Day will unite neurologists, patients, advocates and educators all over the world under the theme "Brain Health and Prevention."

2024-07-15 20:30 3280

United Imaging Announces First PET/CT Installation in Mexico, at Instituto Nacional de Pediatría

MEXICO CITY, July 15, 2024 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has launched its uMI 550 PET/CT system at the Instituto Nacional de Pediatría (INP) inMexico. This partnership reflects a shared commitment between the two organizati...

2024-07-15 20:00 1715

HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer

ROCKVILLE, Md. and SEOUL, South Korea, July 15, 2024 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment ofChristopher W. Slavinsky as Chief Business Development and Legal Officer. HanAll Biopharma Appoints Christopher...

2024-07-15 19:00 2594

CooperVision Champions Children's Eye Health at WCPOS V 2024

Global Myopia Management Leader Showcases Long-Term Benefits of MiSight® 1 day KUALA LUMPUR, Malaysia, July 15, 2024 /PRNewswire/ -- CooperVision , a global leader in myopia management, successfully concluded its impactful participation as a Gold sponsor at the5

2024-07-15 14:00 8767

CPHI & PMEC Shenzhen 2024: Fostering New Opportunities in Asia and China's Greater Bay Area

SHANGHAI, July 15, 2024 /PRNewswire/ -- CPHI & PMEC China 2024 concluded in June with an exceptional turnout of visitors, setting a new attendance record. Notably, the number of international visitors grew to 11,563, and professionals from the end-to-end pharmaceutical supply chain made meaningfu...

2024-07-15 13:59 2404

Everest Medicines Announces Positive Topline Results from Maintenance Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderately-to-Severely Active Ulcerative Colitis

SHANGHAI, July 15, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced positive topline data results of the ...

2024-07-15 13:44 2630

Basecare Medical (2170. HK) revenue growth exceeds 50% in 2024H1

SUZHOU, China , July 15, 2024 /PRNewswire/ -- Basecare Medical (2170. HK) released an unaudited interim performance forecast onJuly 12th, stating that the company's revenue for the first half of the year was approximatelyRMB 127 million to RMB 138 million, an increase of approximately 49% to 62% ...

2024-07-15 12:17 4686

Nona Biosciences Enters into Collaboration Agreement with Alaya.bio to Advance CAR-T Cell Therapy

CAMBRIDGE, Mass., July 14, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery through preclinical research, announced today that it has entered into a collaboration a...

2024-07-15 10:12 1749

Physta® Tongkat Ali: Breakthrough Antiviral Study Reinforces Immune-Boosting & Healthy Ageing Benefits

KUALA LUMPUR, Malaysia, July 15, 2024 /PRNewswire/ -- In a significant breakthrough for the nutraceutical industry, Physta® Tongkat Ali, a proprietary extract of the traditional herbEurycoma longifolia from Biotropics Malaysia, has been spotlighted in a recently published study for its potent ant...

2024-07-15 08:00 8871

Qilian International Holding Group Ltd Regained Compliance with Nasdaq's Minimum Bid Price Rule

CHENGDU, China, July 12, 2024 /PRNewswire/ -- Qilian International Holding Group Limited (NASDAQ: QLI) ("Qilian" or the "Company"), aChina-based pharmaceutical and chemical products manufacturer, today announced that onJuly 10, 2024, NASDAQ notified the Company that it has determined that for the...

2024-07-12 20:30 6921

Senhwa Biosciences Clinical Data Abstract of Pidnarulex Accepted for Presentation at 2024 ESMO Congress

TAIPEI and SAN DIEGO, July 12, 2024 /PRNewswire/ -- Senhwa Biosciences' new drug Pidnarulex (CX-5461) has demonstrated efficacy in treating various solid tumors with BRCA2 or PALB2 gene defects. The abstract of this clinical trial has been selected for presentation at the 2024 European Society fo...

2024-07-12 19:00 5337
1 ... 201202203204205206207 ... 644

Week's Top Stories